Nalaganje...
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
The majority of patients with head and neck squamous cell carcinoma (HNSCC) present with locally advanced disease, which requires site-specific combinations of surgery, radiation, and chemotherapy. Despite aggressive therapy, survival outcomes remain poor, and treatment-related morbidity is not negl...
Shranjeno v:
| izdano v: | Onco Targets Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831599/ https://ncbi.nlm.nih.gov/pubmed/27110122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S93720 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|